Author: Shen Xinglei Zaorsky Nicholas G Mishra Mark V Foley Kathleen A Hyslop Terry Hegarty Sarah Pizzi Laura T Dicker Adam P Showalter Timothy N
Publisher: Future Medicine
ISSN: 1479-6694
Source: Future Oncology, Vol.8, Iss.1, 2012-01, pp. : 37-54
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Comparative effectiveness research aims to help clinicians, patients and policymakers make informed treatment decisions under real-world conditions. Prostate cancer patients have multiple treatment options, including active surveillance, androgen deprivation therapy, surgery and multiple modalities of radiation therapy. Technological innovations in radiation therapy for prostate cancer have been rapidly adopted into clinical practice despite relatively limited evidence for effectiveness showing the benefit for one modality over another. Comparative effectiveness research has become an essential component of prostate cancer research to help define the benefits, risks and effectiveness of the different radiation therapy modalities currently in use for prostate cancer treatment.